Bio-Path Holdings, Inc. (BPTH)
OTCMKTS · Delayed Price · Currency is USD
0.0257
+0.0107 (71.33%)
At close: Sep 4, 2026
Bio-Path Holdings Market Cap
Bio-Path Holdings has a market cap or net worth of $1.29 million as of September 4, 2026. Its market cap has increased by 26.81% in one year.
Market Cap
1.29M
Enterprise Value
1.81M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
ChartMarket Cap Chart
Since February 15, 2008, Bio-Path Holdings's market cap has decreased from 31.22M to 1.29M, a decrease of -95.86%. That is a compound annual growth rate of -15.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.29M | 133.11% |
| Dec 31, 2025 | 554.53K | -88.90% |
| Dec 31, 2024 | 5.00M | -12.65% |
| Dec 29, 2023 | 5.72M | -52.42% |
| Dec 30, 2022 | 12.02M | -55.47% |
| Dec 31, 2021 | 26.99M | 69.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regenerative Medical Technology Group | 1.12M |
| Evofem Biosciences | 1.06M |
| Innovation Pharmaceuticals | 1.06M |
| Neon Bloom | 955.17K |
| ZyVersa Therapeutics | 803.12K |
| Agentix | 801.34K |
| CERo Therapeutics Holdings | 759.29K |
| SQZ Biotechnologies Company | 707.79K |